RecruitingNot ApplicableNCT06629636

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity and IVF Success Rate in Patients Who Have Experienced IVF Failures.


Sponsor

Sunkaky Medical Cooperation

Enrollment

60 participants

Start Date

Aug 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.


Eligibility

Sex: FEMALEMin Age: 32 YearsMax Age: 42 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NMN capsule and Placebo for people with female infertility and repeated ivf failure. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 32 Years to 42 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTNMN capsule

Total of 900mg/day for 8 weeks

OTHERPlacebo

NMN-free placebo capsules for 8 weeks


Locations(1)

IVF Namba Clinic, Sankaky Medical Corporation

Osaka, Osaka, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06629636


Related Trials